当前位置:首页 - 行情中心 - 上海医药(601607) - 财务分析 - 现金流量表

上海医药

(601607)

  

流通市值:466.63亿  总市值:620.41亿
流通股本:27.89亿   总股本:37.08亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金74,380,745,244.37310,476,389,933.39223,734,692,550.11148,688,702,663.69
  收到的税费返还51,627,668.16215,861,045.48152,560,975.79106,985,906.88
  收到其他与经营活动有关的现金1,206,887,070.233,071,842,865.883,582,188,850.872,295,146,319.36
  经营活动现金流入小计75,639,259,982.76313,764,093,844.75227,469,442,376.77151,090,834,889.93
  购买商品、接受劳务支付的现金66,948,554,202.12277,210,199,143.72199,383,937,006.94133,530,822,206.41
  支付给职工以及为职工支付的现金2,849,976,624.7811,384,470,428.27,293,925,442.425,836,065,054.48
  支付的各项税费2,246,061,589.517,699,771,165.265,827,774,466.53,962,697,333.33
  支付其他与经营活动有关的现金4,604,361,940.4811,315,451,728.212,613,995,295.326,771,993,306.82
  经营活动现金流出小计76,648,954,356.89307,609,892,465.38225,119,632,211.18150,101,577,901.04
  经营活动产生的现金流量净额-1,009,694,374.136,154,201,379.372,349,810,165.59989,256,988.89
二、投资活动产生的现金流量:
  收回投资收到的现金6,602,451,639.0664,905,208,473.3750,949,303,686.7636,312,602,000
  取得投资收益收到的现金14,243,328.17533,339,309.47366,774,426.61169,259,831.45
  处置固定资产、无形资产和其他长期资产收回的现金净额106,338,795.63105,146,870.8579,911,584.0567,276,784.19
  处置子公司及其他营业单位收到的现金净额2,617,197.9440,221,651.2424,108,575.1216,865,471.79
  收到的其他与投资活动有关的现金60,000,0001,435,611,552.971,388,824,8001,125,180,875.51
  投资活动现金流入小计6,785,650,960.867,019,527,857.952,808,923,072.5437,691,184,962.94
  购建固定资产、无形资产和其他长期资产支付的现金687,114,232.512,325,878,841.631,612,196,921.121,124,571,482.54
  投资支付的现金6,315,309,056.7266,832,506,032.9149,914,249,00036,028,414,840
  取得子公司及其他营业单位支付的现金-280,306,149.16656,284,741626,709,265.26
  支付其他与投资活动有关的现金70,000,0001,563,066,489.91,416,500,364.131,151,755,000
  投资活动现金流出小计7,072,423,289.2371,001,757,513.653,599,231,026.2538,931,450,587.8
  投资活动产生的现金流量净额-286,772,328.43-3,982,229,655.7-790,307,953.71-1,240,265,624.86
三、筹资活动产生的现金流量:
  吸收投资收到的现金-23,928,175.77,378,175.77,378,175.7
  其中:子公司吸收少数股东投资收到的现金-16,550,000--
  取得借款收到的现金20,209,326,091.7661,326,650,569.9148,090,270,678.1535,773,622,565.68
  发行债券收到的现金2,999,852,5007,997,083,333.337,997,083,333.335,997,825,000
  收到其他与筹资活动有关的现金82,501,000220,182,772.32198,437,899.47176,698,086.4
  筹资活动现金流入小计23,291,679,591.7669,567,844,851.2656,293,170,086.6541,955,523,827.78
  偿还债务支付的现金22,124,665,813.9470,215,579,438.4552,938,358,758.1136,315,299,388
  分配股利、利润或偿付利息支付的现金830,241,941.483,851,752,338.093,133,071,878.371,347,824,733.59
  其中:子公司支付给少数股东的股利、利润155,045,608.191,051,801,460.89758,979,753.81488,040,452.9
  支付其他与筹资活动有关的现金184,430,354.991,152,281,453.3775,374,455.43539,022,568.43
  筹资活动现金流出小计23,139,338,110.4175,219,613,229.8456,846,805,091.9138,202,146,690.02
  筹资活动产生的现金流量净额152,341,481.35-5,651,768,378.58-553,635,005.263,753,377,137.76
四、汇率变动对现金及现金等价物的影响-8,778,258.86-3,115,599.14-11,454,659.07-13,772,678.98
五、现金及现金等价物净增加额-1,152,903,480.07-3,482,912,254.05994,412,547.553,488,595,822.81
  加:期初现金及现金等价物余额28,398,360,540.8231,881,272,794.8731,881,272,794.8731,881,272,794.87
  期末现金及现金等价物余额27,245,457,060.7528,398,360,540.8232,875,685,342.4235,369,868,617.68
补充资料:
  净利润-6,973,717,681.49-4,994,784,030.29
  资产减值准备-1,018,555,938.73-410,078,463.89
  固定资产和投资性房地产折旧-1,512,910,120.05-767,496,142.84
  无形资产摊销-602,493,205.87-255,283,712.67
  长期待摊费用摊销-198,488,749.61-98,405,948.12
  处置固定资产、无形资产和其他长期资产的损失--157,152,717.09--39,986,393.32
  公允价值变动损失--332,120,868.45--75,751,833.73
  财务费用-1,669,610,270.78-894,866,769.55
  投资损失--3,409,098,249.27--3,353,837,518.88
  递延所得税-572,259,675.46-572,280,216.64
  其中:递延所得税资产减少-37,097,310.92--41,775,560.74
    递延所得税负债增加-535,162,364.54-614,055,777.38
  存货的减少--5,196,581,328.95--727,190,985.67
  经营性应收项目的减少--3,668,534,969.05--7,208,369,490.15
  经营性应付项目的增加-5,048,228,397.42-3,633,443,202.94
  现金的期末余额-28,398,360,540.82-35,369,868,617.68
  减:现金的期初余额-31,881,272,794.87-31,881,272,794.87
  现金及现金等价物的净增加额--3,482,912,254.05-3,488,595,822.81
公告日期2026-04-302026-03-312025-10-312025-08-29
审计意见(境内)标准无保留意见
TOP↑